AstraZeneca Pharma rallies 4% on permission from drug controller to market diabetes drug News News / News 6 years ago 436 Views comments The drug firm has received marketing authorisation from the Drug Controller General of India (DCGI) for Xigduo XR tablets used in the treatment of adu... Read more
News YES Bank, EIB in pact to lend $400 m for renewable energy projects over 15 years News / News - 6 years ago
Comments